Literature DB >> 29922915

Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study.

Francesca Floris1, Federica Comitini1, GiovanBattista Leoni2, Paolo Moi1, Maddalena Morittu2, Valeria Orecchia2, Maria Perra2, Maria Paola Pilia2, Antonietta Zappu2, Maria Rosaria Casini2, Raffaella Origa3.   

Abstract

PURPOSE: The aim of this study has been to evaluate the physical, psychological, and social well-being in a large group of Sardinian adult patients with transfusion-dependent beta-Thalassemia when compared with a group of healthy subjects of the same age and geographical extraction.
METHODS: Male or female patients ≥ 18 years of age with Thalassemia major on regular transfusion at Thalassemia Center in Cagliari (Italy) were requested to complete the World Health Organization Quality of life-BREF (WHOQOL-BREF) questionnaire. The WHOQOL-BREF was also made available online to age- and sex-matched non-thalassemic adult subjects living in Sardinia.
RESULTS: Two hundred and seven subjects with Thalassemia were invited to participate in the study. The questionnaire was also completed by 211 age- and sex-matched non-thalassemic subjects living in Sardinia. Scores suggestive of a good quality of life were obtained in all the areas investigated. Thalassemia patients had scores at least as good as those of non-thalassemic subjects in all items and the percentage of those with a score ≥ 60 was higher among patients. The analysis of demographic actually highlights that the disease has a little effect on their personal and social lives. There was a positive association between subjective well-being and effective clinical conditions. Moreover, the association between health perception and adherence to treatment suggests that compliance with treatment contributes to the well-being of the patient, both physically and psychologically.
CONCLUSIONS: Adult subjects with Thalassemia who live in Western countries have a good quality of life in accordance with the advances in the management of the disease.

Entities:  

Keywords:  General health; Physical health; Psychological health; Quality of life; Thalassemia major; WHOQOL-BREF

Mesh:

Year:  2018        PMID: 29922915     DOI: 10.1007/s11136-018-1911-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

1.  Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Authors:  Paul Telfer; Pietro G Coen; Soteroula Christou; Michael Hadjigavriel; Anita Kolnakou; Evangelia Pangalou; Nicos Pavlides; Michael Psiloines; Krikor Simamonian; Georghios Skordos; Maria Sitarou; Michael Angastiniotis
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

2.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

3.  Factors Affecting Quality of Life in Adult Patients with Thalassaemia Major and Intermedia.

Authors:  Gin Gin Gan; Yuen Ling Hue; Jameela Sathar
Journal:  Ann Acad Med Singapore       Date:  2016-11       Impact factor: 2.473

4.  Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgio La Nasa; Giovanni Caocci; Fabio Efficace; Carlo Dessì; Adriana Vacca; Eugenia Piras; Marco Sanna; Michela Marcias; Roberto Littera; Carlo Carcassi; Guido Lucarelli
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

5.  Health-related Quality of Life and its Predictors Among Transfusion-dependent Thalassemia Patients.

Authors:  Gulen Tuysuz; Funda Tayfun
Journal:  J Pediatr Hematol Oncol       Date:  2017-07       Impact factor: 1.289

6.  [Type 2 Diabetes and Short Form 36-items Health Survey].

Authors:  F Clouet; G Excler-Cavailher; B Christophe; F Masson; D Fasquel
Journal:  Diabetes Metab       Date:  2001-12       Impact factor: 6.041

7.  Psychometric properties of the Specific Thalassemia Quality of Life Instrument for adults.

Authors:  Georgios N Lyrakos; Demetra Vini; Helen Aslani; Marouso Drosou-Servou
Journal:  Patient Prefer Adherence       Date:  2012-07-02       Impact factor: 2.711

Review 8.  Thalassaemia in children: from quality of care to quality of life.

Authors:  Ali Amid; Antoine N Saliba; Ali T Taher; Robert J Klaassen
Journal:  Arch Dis Child       Date:  2015-08-19       Impact factor: 3.791

9.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

Review 10.  Thalassemia 2016: Modern medicine battles an ancient disease.

Authors:  Deborah Rund
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

View more
  4 in total

Review 1.  Luspatercept: A Gigantic Step in the Treatment of Transfusion-Dependent β-Thalassemia Patients-a Quick Review.

Authors:  Hadi Darvishi-Khezri; Hossein Karami
Journal:  Adv Ther       Date:  2021-03-04       Impact factor: 3.845

Review 2.  Pregnancy in Thalassemia.

Authors:  Raffaella Origa; Federica Comitini
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576

3.  Quality of life and challenges experienced by the surviving adults with transfusion dependent thalassaemia in Malaysia: a cross sectional study.

Authors:  Wai Cheng Foong; Kooi Yau Chean; Fairuz Fadzilah Rahim; Ai Sim Goh; Seoh Leng Yeoh; Angeline Aing Chiee Yeoh
Journal:  Health Qual Life Outcomes       Date:  2022-01-08       Impact factor: 3.186

4.  Gender Differences in Knowledge and Perception of Cardiovascular Disease among Italian Thalassemia Major Patients.

Authors:  Antonella Meloni; Laura Pistoia; Silvia Maffei; Paolo Marcheschi; Tommaso Casini; Anna Spasiano; Pier Paolo Bitti; Liana Cuccia; Elisabetta Corigliano; Paola Maria Grazia Sanna; Francesco Massei; Vincenzo Positano; Filippo Cademartiri
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.